Brief: Upmc And Pitt Develop New Cancer Immunotherapy With Avalon Globocare
Aug 4 (Reuters) - Avalon Globocare Corp AVCO.O :
* UPMC AND PITT DEVELOP NEW CANCER IMMUNOTHERAPY WITH AVALON
GLOBOCARE
Source text for Eikon: ID:nGNX1zRlgf
Further company coverage: AVCO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Change Agents
See all newsBrief: Change Agents Corporation - Meng Li Resigns As Interim CEO, COO, And Secretary Effective October 8, 2026
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 09:30 PM